ALS (DB:CP4) - Stock Price, News & Analysis

CP4 Stock Overview

Provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. More details

CP4 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	5/6
Past Performance	0/6
Financial Health	3/6
Dividends	3/6

Rewards

Earnings are forecast to grow 28.59% per year

Risk Analysis

Has a high level of debt

Large one-off items impacting financial results

Profit margins (0.2%) are lower than last year (11.1%)

Dividend of 2.43% is not well covered by earnings

ALS Limited Competitors

Bertrandt

XTRA:BDT

€182.4m

Avemio

XTRA:3D6

€29.9m

Bilfinger

XTRA:GBF

€1.7b

Amadeus FiRe

XTRA:AAD

€418.3m

Price History & Performance

Summary of all time highs, changes and price drops for ALS
Historical stock prices
Current Share Price	AU$9.95
52 Week High	AU$9.95
52 Week Low	AU$7.05
Beta	1.17
11 Month Change	17.06%
3 Month Change	5.29%
1 Year Change	38.19%
33 Year Change	33.56%
5 Year Change	76.11%
Change since IPO	22.59%

Recent updates

Shareholder Returns

	CP4	DE Professional Services	DE Market
7D	11.8%	0.7%	-0.02%
1Y	38.2%	-52.1%	8.2%

Return vs Industry: CP4 exceeded the German Professional Services industry which returned -52.1% over the past year.

Return vs Market: CP4 exceeded the German Market which returned 8.2% over the past year.

Price Volatility

Is CP4's price volatile compared to industry and market?
CP4 volatility
CP4 Average Weekly Movement	4.6%
Professional Services Industry Average Movement	4.0%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.3%

Stable Share Price: CP4 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: CP4's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1863	19,565	Malcolm Deane	www.alsglobal.com

ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies.

ALS Limited Fundamentals Summary

How do ALS's earnings and revenue compare to its market cap?
CP4 fundamental statistics
Market cap	€4.89b
Earnings (TTM)	€3.87m
Revenue (TTM)	€1.69b

1,263x

P/E Ratio

2.9x

P/S Ratio

Is CP4 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CP4 income statement (TTM)
Revenue	AU$2.70b
Cost of Revenue	AU$1.90b
Gross Profit	AU$805.80m
Other Expenses	AU$799.60m
Earnings	AU$6.20m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

May 27, 2025

Earnings per share (EPS)	0.013
Gross Margin	29.81%
Net Profit Margin	0.23%
Debt/Equity Ratio	142.7%

How did CP4 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

3,003%

Payout Ratio

Does CP4 pay a reliable dividends?

See CP4 dividend history and benchmarks

When do you need to buy CP4 by to receive an upcoming dividend?
ALS dividend dates
Ex Dividend Date	Nov 27 2024
Dividend Pay Date	Dec 19 2024
Days until Ex dividend	3 days
Days until Dividend pay date	25 days

Does CP4 pay a reliable dividends?

See CP4 dividend history and benchmarks

CP4 Stock Overview

Rewards

Risk Analysis

ALS Limited Competitors

XTRA:BDT

€182.4m

XTRA:3D6

€29.9m

XTRA:GBF

€1.7b

XTRA:AAD

€418.3m

Price History & Performance

Recent News & Updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

Recent updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021